Literature DB >> 17488742

Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha.

Barbara D Abbott1, Cynthia J Wolf, Judith E Schmid, Kaberi P Das, Robert D Zehr, Laurence Helfant, Shoji Nakayama, Andrew B Lindstrom, Mark J Strynar, Christopher Lau.   

Abstract

Perfluorooctanoic acid (PFOA) is a member of a family of perfluorinated chemicals that have a variety of applications. PFOA persists in the environment and is found in wildlife and humans. In mice, PFOA is developmentally toxic producing mortality, delayed eye opening, growth deficits, and altered pubertal maturation. PFOA activates peroxisome proliferators-activated receptor-alpha (PPARalpha), a pathway critical to the mode of induction of liver tumors in rodents. The present study uses 129S1/SvlmJ wild-type (WT) and PPARalpha knockout (KO) mice to determine if PPARalpha mediates PFOA-induced developmental toxicity. Pregnant mice were dosed orally from gestation days 1-17 with water or 0.1, 0.3, 0.6, 1, 3, 5, 10, or 20 mg PFOA/kg. PFOA did not affect maternal weight, embryonic implantation, number, or weight of pups at birth. At 5 mg/kg, the incidence of full litter resorptions increased in both WT and KO mice. In WT, but not KO, neonatal survival was reduced (0.6 mg/kg) and eye opening was delayed (1 mg/kg). There was a trend across dose for reduced pup weight (WT and KO) on several postnatal days (PND), but only WT exposed to 1 mg/kg were significantly different from control (PND7-10 and 22). Maternal factors (e.g., background genetics) did not contribute to differences in postnatal mortality, as PFOA induced postnatal mortality in heterozygous pups born to WT or KO dams. In conclusion, early pregnancy loss was independent of PPARalpha expression. Delayed eye opening and deficits in postnatal weight gain appeared to depend on PPARalpha expression, although other mechanisms may contribute. PPARalpha was required for PFOA-induced postnatal lethality and expression of one copy of the gene was sufficient to mediate this effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488742     DOI: 10.1093/toxsci/kfm110

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  56 in total

1.  Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.

Authors:  Adam J Filgo; Erin M Quist; Mark J Hoenerhoff; Amy E Brix; Grace E Kissling; Suzanne E Fenton
Journal:  Toxicol Pathol       Date:  2014-11-14       Impact factor: 1.902

2.  Effects of chronic perfluorooctanoic acid (PFOA) at low concentration on morphometrics, gene expression, and fecundity in zebrafish (Danio rerio).

Authors:  Carrie E Jantzen; Fatima Toor; Kate A Annunziato; Keith R Cooper
Journal:  Reprod Toxicol       Date:  2017-01-29       Impact factor: 3.143

3.  Environmental and biological monitoring of persistent fluorinated compounds in Japan and their toxicities.

Authors:  Kouji H Harada; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2008-11-11       Impact factor: 3.674

4.  Ammonium perfluorooctanoate may cause testosterone reduction by adversely affecting testis in relation to PPARα.

Authors:  Yufei Li; Doni Hikmat Ramdhan; Hisao Naito; Nozomi Yamagishi; Yuki Ito; Yumi Hayashi; Yukie Yanagiba; Ai Okamura; Hazuki Tamada; Frank J Gonzalez; Tamie Nakajima
Journal:  Toxicol Lett       Date:  2011-06-25       Impact factor: 4.372

5.  PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression.

Authors:  Vijay R More; Christopher R Campos; Rebecca A Evans; Keith D Oliver; Gary Ny Chan; David S Miller; Ronald E Cannon
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  Peroxisome proliferator-activated receptors alpha, Beta, and gamma mRNA and protein expression in human fetal tissues.

Authors:  Barbara D Abbott; Carmen R Wood; Andrew M Watkins; Kaberi P Das; Christopher S Lau
Journal:  PPAR Res       Date:  2010-07-26       Impact factor: 4.964

7.  Developmental effects of perfluorononanoic Acid in the mouse are dependent on peroxisome proliferator-activated receptor-alpha.

Authors:  Cynthia J Wolf; Robert D Zehr; Judy E Schmid; Christopher Lau; Barbara D Abbott
Journal:  PPAR Res       Date:  2010-09-27       Impact factor: 4.964

8.  Gene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent Effects.

Authors:  Mitchell B Rosen; Judith R Schmid; J Christopher Corton; Robert D Zehr; Kaberi P Das; Barbara D Abbott; Christopher Lau
Journal:  PPAR Res       Date:  2010-09-27       Impact factor: 4.964

9.  Interaction of perfluorooctanoic acid with human serum albumin.

Authors:  Ling-Ling Wu; Hong-Wen Gao; Nai-Yun Gao; Fang-Fang Chen; Ling Chen
Journal:  BMC Struct Biol       Date:  2009-05-14

10.  Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth.

Authors:  Noriaki Washino; Yasuaki Saijo; Seiko Sasaki; Shizue Kato; Susumu Ban; Kanae Konishi; Rie Ito; Ayako Nakata; Yusuke Iwasaki; Koichi Saito; Hiroyuki Nakazawa; Reiko Kishi
Journal:  Environ Health Perspect       Date:  2008-11-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.